Litigation Details for Bristol-Myers Squibb Co. v. AstraZeneca Pharmaceuticals LP (D. Del. 2023)
✉ Email this page to a colleague
Bristol-Myers Squibb Co. v. AstraZeneca Pharmaceuticals LP (D. Del. 2023)
| Docket | ⤷ Sign Up | Date Filed | 2023-01-23 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | |
| Jury Demand | Plaintiff | Referred To | |
| Parties | BRISTOL-MYERS SQUIBB CO. | ||
| Patents | 8,685,394; 9,320,811 | ||
| Attorneys | Rachel J. Elsby | ||
| Firms | Akin Gump Strauss Hauer & Feld LLP | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in Bristol-Myers Squibb Co. v. AstraZeneca Pharmaceuticals LP
The biologic drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Bristol-Myers Squibb Co. v. AstraZeneca Pharmaceuticals LP (D. Del. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2023-01-23 | 1 | Complaint | 384,900, filed January 19, 2012 (now U.S. Patent No. 8,685,394), which is a national stage entry of PCT…of the ’811 patent since the ’811 patent issued. Defendants own or control numerous patents covering IMJUDO…of the ’135 patent since the ’135 patent issued. Defendants own or control numerous patents covering IMFINZI…Moreover, the ’135 patent belongs to the same family of patents as two of the patents asserted in the IMFINZI…respect BMS’s patent rights just as Defendants expect third parties to respect their patent rights. | External link to document |
| 2023-07-31 | 21 | Patent/Trademark Report to Commissioner of Patents | HOLDER OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 US 9,320,811 B2 …Trademarks or ✔ Patents. G ( G the patent action involves 35…AstraZeneca AB L.L.C. PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT …REPORT ON THE TO: Director of the U.S. Patent and Trademark Office FILING | External link to document |
| 2023-01-23 | 3 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,320,811 B2; US 9,273,135 …HOLDER OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 US 9,320,811 B2 …Trademarks or ✔ Patents. G ( G the patent action involves 35…AstraZeneca AB L.L.C. PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT | External link to document |
| 2023-02-15 | 7 | Counterclaim AND Answer to Complaint | 384,900, filed January 19, 2012 (now U.S. Patent No. 8,685,394), which is a national stage entry of PCT…384,900, filed January 19, 2012 (now U.S. Patent No. 8,685,394), which is a national stage entry of PCT…CTLA-4 patent portfolio, Defendants investigated BMS’s portfolio of CTLA-4-related patents and patent applications…of the ’811 patent since the ’811 patent issued. Defendants own or control numerous patents covering IMJUDO…of the ’135 patent since the ’135 patent issued. Defendants own or control numerous patents covering IMFINZI | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
